Immunohistochemistry showed that the IPMN component was MUC1 (+)/MUC2 (+)/MUC5AC (+)/CDX2 (+)/p-CK (+)/CK19 (+)/P53 (20%)/Ki67 (15–30%) (Fig. 2). This evidence concerns the gene CDX2 and pancreatic intraductal papillary-mucinous neoplasm.